BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Guo GJ, Yao F, Lu WP, Xu HM. Gut microbiome and metabolic-associated fatty liver disease: Current status and potential applications. World J Hepatol 2023; 15(7): 867-882 [PMID: 37547030 DOI: 10.4254/wjh.v15.i7.867]
URL: https://www.wjgnet.com/1948-5182/full/v15/i7/867.htm
Number Citing Articles
1
Federica Fogacci, Marina Giovannini, Valentina Di Micoli, Elisa Grandi, Claudio Borghi, Arrigo Francesco Giuseppe Cicero. Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical TrialNutrients 2024; 16(15): 2454 doi: 10.3390/nu16152454
2
Aneta Sokal-Dembowska, Sara Jarmakiewicz-Czaja, Rafał Filip. Flavonoids and Their Role in Preventing the Development and Progression of MAFLD by Modifying the MicrobiotaInternational Journal of Molecular Sciences 2024; 25(20): 11187 doi: 10.3390/ijms252011187
3
Maryline Roy, Anne Dumay, Sandrine Adiba, Sylvana Rozes, Seiki Kobayashi, Valérie Paradis, Catherine Postic, Dominique Rainteau, Eric Ogier-Denis, Maude Le Gall, Ulrich Meinzer, Emilie Viennois, Maite Casado-Bedmar, Alexis Mosca, Jean-Pierre Hugot. Entamoeba muris mitigates metabolic consequences of high-fat diet in mice Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2409210
4
Hong Lu. Inflammatory liver diseases and susceptibility to sepsisClinical Science 2024; 138(7): 435 doi: 10.1042/CS20230522